טוען...
Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
Renin–angiotensin–aldosterone system (RAAS) inhibitors are the key medications for patients with heart failure and chronic kidney disease. Multiple randomized controlled trials have demonstrated their benefits in an outpatient setting for the treatment of chronic heart failure. Additional advantages...
שמור ב:
| הוצא לאור ב: | Drugs Context |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioExcel Publishing Ltd
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7673621/ https://ncbi.nlm.nih.gov/pubmed/33240389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-7-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|